Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists ...

Researchers have demonstrated that opioid delta-receptor agonists alleviate stress-induced irritable bowel syndrome symptoms in a validated mouse model Irritable bowel syndrome (IBS) is a common ...

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and ...

HURA READ THE FULL HURA RESEARCH REPORT We are initiating coverage of TuHURA Biosciences, Inc. (NASDAQ:HURA) with a valuation ...

Investment analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s ...